Semergen
SGLT2i compared to other non-insulin antidiabetics in Primary Care patients with earlier diabetes. Cohort profile and sample characteristics of DIAB-CV-AP study.
J Pablo-Ortega, D Rey-Aldana, A Segura-Fragoso, P Mazón-Ramos, M Portela-Romero, J R González-Juanatey, S Cinza-Sanjurjo
Published: 202610.1016/j.semerg.2025.102667
Abstract
AIM: To describe the methodology and baseline characteristics of the sample of the DIAB-CV-AP study which, as a general objective of the cohort, aims to analyse the possible protective effect of iSGLT2 associated with metformin in patients with T2DM.…
Preview only. Read the full abstract at the source